Do you want to read an article? Please log in or register.
Salvage proton beam therapy for recurrent iris melanoma: outcome and side effects
Glaucoma and Ocular PressureOcular Oncology
Related content
Ocular Oncology
Corneal Substructure Dosimetry Predicts Corneal Toxicity in Patients with Uveal Melanoma Treated with Proton Beam Therapy
Int J Radiat Oncol Biol Phys.
Lee HJ Jr, Stacey A, Klesert TR, Wells C, Skalet A, Bloch C, Fung A, Bowen SR, Wong TP, Shibata D, Halasz LM, Rengan R
doi: 10.1016/j.ijrobp.2019.02.005.
Ocular Oncology
Effects of plaque brachytherapy and proton beam radiotherapy on prognostic testing: a comparison of uveal melanoma genotyped by microsatellite analysis
Br J Ophthalmol.
Thornton S, Coupland SE, Heimann H, Hussain R, Groenewald C, Kacperek A, Damato B, Taktak A, Eleuteri A, Kalirai H
doi: 10.1136/bjophthalmol-2019-315363.
Ocular Oncology
Robotic assisted CyberKnife radiosurgery for the treatment of iris melanoma
Sci Rep
Schmelter V, Heidorn S, Muacevic A, Priglinger SG, Foerster P, Liegl R
doi: 10.1038/s41598-021-84290-x
Ocular Oncology
Dose-response and normal tissue complication probabilities after proton therapy for choroidal melanomas
Ophthalmology.
Espensen CA, Kiilgaard JF, Appelt AL, Fog LS, Herault J, Maschi C, Caujolle JP, Thariat J
doi: 10.1016/j.ophtha.2020.06.030.
Macular DiseasesOcular Oncology
Occurrence of phosphenes in patients undergoing proton beam therapy for ocular tumor
Am J Ophthalmol.
Mathis T, Hofverberg P, Caujolle JP, Hérault J, Leal C, Maschi C, Delaunay B, Baillif S, Kodjikian L, Thariat J
doi: 10.1016/
Ocular Oncology
A prospective trial of adjuvant therapy for high-risk uveal melanoma: assessing 5-year survival outcomes
Br J Ophthalmol.
Binkley E, Triozzi PL, Rybicki L, Achberger S, Aldrich W, Singh A
doi: 10.1136/bjophthalmol-2019-314461.
Retinal Diseases
Photodynamic therapy in combination with intravitreal ziv-aflibercept and aflibercept injection in patients with chronic or repeatedly recurrent acute central serous chorioretinopathy: a single-center retrospective study
Clin Ophthalmol.
Doepfner JM, Michels S, Graf N, Becker MD, Freiberg FJ
doi: 10.2147/OPTH.S165199.
RECOMMENDED
Ocular Oncology
Photodynamic Therapy for Choroidal Metastasis Tumor Control and Visual Outcomes in 58 Cases: The 2019 Burnier International Ocular Pathology Society Lecture
★ 2
Recommended by
Prof. Dr Daniel Barthelmes, Faculty Member
Ophthalmol Retina.
Shields CL, Khoo CTL, Mazloumi M, Mashayekhi A, Shields JA
doi: 10.1016/j.oret.2019.10.009.
Further Publications
<i>Acanthamoeba</i> keratitis therapy: time to cure and visual outcome analysis for different antiamoebic therapies in 227 cases
Br J Ophthalmol.
Papa V, Rama P, Radford C, Minassian DC, Dart JKG
doi: 10.1136/bjophthalmol-2019-314485.